节点文献

中药外敷联合克拉霉素治疗慢性前列腺炎的临床观察

Clinical Observation on External Application of Chinese Herbal Medicine Combined with Clarithromycin in Treating Chronic Prostatitis

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 钟林芝张文龙孟农钦杨文涛

【通讯作者】 杨文涛;

【机构】 广西中医院大学研究生学院广西中医药大学附属瑞康医院

【摘要】 目的:观察中药外敷联合克拉霉素治疗慢性前列腺炎的临床疗效。方法:收集2017年6月至2018年6月期间就诊于广西中医药大学附属瑞康医院男性科门诊的120例湿热下注兼血瘀证的慢性前列腺炎患者,随机分为治疗组和对照组,各60例,治疗组采用中药外敷联合口服克拉霉素治疗;对照组仅采用口服克拉霉素治疗,4周为一个疗程,共1个疗程的治疗周期。结果:治疗1个疗程后,治疗组与对照组比较,在总体疗效方面差异有统计学意义(P<0.05),治疗组疗效明显优于对照组;在慢性前列腺炎症状积分指数(NIH-CPSI评分)、中医证候学评分和前列腺液白细胞计数(EPS-WBC)方面,差异有统计学意义(P<0.05),治疗组显著优于对照组。结论:中药外敷联合克拉霉素治疗治疗慢性前列腺炎疗效显著,在NIH-CPSI、中医证候学评分和EPS-WBC计数方面改善明显,值得临床推广。

【Abstract】 Objective: To observe the clinical efficacy of external application of Chinese herbal medicine combined with clarithromycin in the treatment of chronic prostatitis. Method: A total of 120 patients with chronic prostatitis who were treated with damp invasion of lower energizer and blood stasis syndrome at the male clinic of Ruikang Hospital affiliated to Guangxi University of Chinese Medicine from June 2017 to June 2018 were randomly divided into treatment group and control group. 60 cases of each group, the treatment group was treated with external application of Chinese herbal medicine and oral clarithromycin; the control group was only treated with oral clarithromycin, 4 weeks for one course of treatment, a total of 1 course of treatment. Result: After one course of treatment, the difference between the treatment group and the control group was statistically significant(P<0.05). The treatment group was significantly better than the control group; the index of chronic prostatitis symptoms(NIH-CPSI), TCM syndrome scores, and prostatic fluid leukocyte counts(EPS-WBC) were statistically significant(P<0.05), and the treatment group was significantly better than the control group. Conclusion: External application of Chinese herbal medicine combined with clarithromycin has significant curative effect on chronic prostatitis. It is obviously improved in NIH-CPSI, TCM syndrome score and EPS-WBC, which is worthy of clinical promotion.

  • 【文献出处】 大众科技 ,Popular Science & Technology , 编辑部邮箱 ,2019年02期
  • 【分类号】R697.33
  • 【下载频次】80
节点文献中: 

本文链接的文献网络图示:

本文的引文网络